| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
03.12.2019 US 201962943077 P
10.12.2019 US 201962946295 P
10.01.2020 US 202016740329
11.01.2020 US 202016740409
11.01.2020 US 202016740410
11.01.2020 US 202016740411
|
| (71) |
Applicant: Axsome Therapeutics, Inc. |
|
New York, NY 10007 (US) |
|
| (72) |
Inventor: |
|
- TABUTEAU, Herriot
New York, New York 10007 (US)
|
| (74) |
Representative: Biggi, Cristina |
|
Bugnion S.p.A.
Viale Lancetti 17
20158 Milano
20158 Milano (IT) |
|
